A Midtown Manhattan building, formerly housing Pfizer offices and undergoing conversion to residences, was evacuated due to structural concerns. Officials discovered buckling support columns and sagging upper floors.

This incident raises immediate questions for real estate developers and investors in the New York City market. The conversion project's halt and potential repair costs could significantly impact the developer's balance sheet and the project's timeline. Furthermore, it may trigger stricter inspections for similar ongoing or planned conversions across the city.

The safety concerns at the 211 West 56th Street building could also affect property values in the immediate vicinity and potentially slow down the pace of residential conversions in older commercial buildings if widespread issues are suspected.